Human Parvovirus B19 IgG Antibody ELISA Kit

This kit is used for qualitative detection of parvovirus B19 IgG antibody in serum or plasma from pregnant women and pregnant women. Human parvovirus B19 is transmitted through the respiratory tract, pregnant women susceptible to up to 23%~45%, if pregnancy women infected with B19, the fetus infection rate is 33% through the placenta, the incidence of stillbirth 6.5%, the incidence of non immune fetal edema 8%~10%. Specific IgM and IgG antibodies are tested to diagnose whether pregnant women are infected with B19 virus. The appearance of IgG antibodies indicates previous infection, IgG antibodies remain positive all their lives and generally obtain lifelong immunity. If pregnant women have a certain level of anti-b19 virus specific IgG, it can protect the fetus, reduce the damage of B19 virus infection. Serological test to detect specific IgG and IgM antibodies is the basis for the diagnosis of B19 infection. Antibody detection methods mainly include radioimmunoassay (RIA) enzyme (ELISA) immunofluorescence assay (IF) and immunoblot assay (WB). This kit assists the detection of parvovirus B19 in pregnant women.